相关实验视频
Updated: Sep 13, 2025

16:41
Experimental Approaches to Tissue Engineering
Published on: August 30, 2007
6.5K
老疗法:里程碑,创新和未来的前景
Erdem Atasever1, Mehmet Can Atayik2, Ufuk Çakatay1
1Department of Medical Biochemistry, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, İstanbul, Türkiye.
Advances in pharmacology (San Diego, Calif.)
|July 27, 2025
概括
老年药理学研究老年人如何对药物的反应,解决独特的挑战,如改变的药理动力学和并发症. 研究探讨现有的药物和新的老年治疗方法,包括人工智能辅助的老年治疗发现.
科学领域:
- 生物医学老年学 生物医学老年学
- 遗传药理学 遗传药理学是一门学科.
背景情况:
- 老年学实践已经发展,导致生物医学老年学等专业领域.
- 老年药理学作为一个独特的子领域出现,专注于老年人的药物干预.
- 越来越多的老年人口及其复杂的健康需求强调了老年药理学的重要性.
研究的目的:
- 探索日老药理学不断发展的领域及其在管理老年人健康方面的重要性.
- 审查关于传统药理学药物和新型老年治疗药物的当前研究.
- 讨论老年医疗实践中老年治疗药物发现的潜力和局限性.
主要方法:
- 审查关于老年药理学和老年治疗的现有文献.
- 在老年人中研究常规药理学药物 (例如,奎尔塞丁,拉帕米辛,甲胺).
- 探索人工智能辅助的老年治疗药物发现及其挑战.
主要成果:
- 老年药理学针对老年人的药理学变化和并发症.
- 研究包括评估现有药物和开发新的老年治疗药物.
- 经疗法方法有希望,但由于非特异性作用和异质细胞表型,面临临临床局限性.
结论:
- 老年药理学对于优化老龄人口药物使用至关重要.
- 老年疗法为与衰老相关的疾病提供了潜力,但需要仔细的临床考虑.
- 了解衰老是一种寿命过程,而不仅仅是衰老,是治疗发展的关键.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K

